North America Point Of Care Molecular Testing For Infectious Diseases Market Size And Share

  • Report Code : TIPRE00039163
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 162
Buy Now

North America Point-of-Care Molecular Testing for Infectious Diseases Market Size, Share, and Growth 2023-2031

Buy Now

North America Point-of-Care Molecular Testing for Infectious Diseases Market Report North America Point-of-Care Molecular Testing for Infectious Diseases Market Scope and Analysis North America Point-of-Care Molecular Testing for Infectious Diseases Market Size and Share

North America Point-of-Care Molecular Testing for Infectious Diseases Market: Size and Share

North America Point-of-Care Molecular Testing for Infectious Diseases Market

  • CAGR (2023 - 2031)
    11.5%
  • Market Size 2023
    US$ 1.09 billion
  • Market Size 2031
    US$ 2.62 billion

Market Dynamics

GROWTH DRIVERS
  • surging prevalence of infectious diseases
  • Ramping preference for rapid diagnostic solutions
FUTURE TRENDS
  • Diversified applications across oncology and chronic disease management
  • Rise in home and self-testing reflected to support market
  • Expanding healthcare infrastructure
OPPORTUNITIES
  • Increasing focus on R&D and funding in infectious diseases diagnostics
  • Development of new products

Market Segmentation

Diseases
  • HIV Testing
  • Influenza Testing
  • Sexually Transmitted Diseases Testing
  • Hepatitis C Virus Testing
  • Tropical Diseases Testing
  • Respiratory Infection Testing
  • Hospital Acquired Infections
  • Strep
Technology
  • Lateral Flow Assay
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Solid Phase
Prescription Testing
  • Prescription Based Testing
  • OTC Testing
Sample
  • Blood Sample
  • Urine Sample
  • Nasal and Oropharyngeal Swabs Sample

North America Point-of-Care Molecular Testing for Infectious Diseases Market Players Density: Understanding Its Impact on Business Dynamics

The North America Point-of-Care Molecular Testing for Infectious Diseases Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the North America Point-of-Care Molecular Testing for Infectious Diseases Market are:

  1. Abbott Laboratories
  2. Agilent Technologies Inc
  3. Becton Dickinson and Co
  4. Bio-Rad Laboratories Inc
  5. Cardinal Health Inc,
  6. Danaher Corp

Disclaimer: The companies listed above are not ranked in any particular order.


north-america-point-of-care-molecular-testing-for-infectious-diseases-market-speedometer

  • Get the North America Point-of-Care Molecular Testing for Infectious Diseases Market top key players overview